26
GPT2/ALT2, human recombinant | 7806
- SKU:
- 26-7806-GEN
- Availability:
- Usually shipped in 5 working days
Description
Alanine aminotransferase 2, also known as GPT2, catalyzes the reversible transamination between alanine and 2-oxoglutarate to form pyruvate and glutamate. Subsequently, they play a key role in the intermediary metabolism of glucose and amino acids. GPT2 expression is high in muscle, fat and kidney. Recombinant human GPT2 protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography techniques.
7806 | GPT2/ALT2 human recombinant DataSheet
Biomolecule/Target: GPT2/ALT2
Synonyms: Alanine aminotransferase 2, AAT2, ALT2
Alternates names: Alanine aminotransferase 2, AAT2, ALT2
Taglines: Catalyzes the reversible transamination between alanine and 2-oxoglutarate to form pyruvate and glutamate
NCBI Gene ID #: 56636
NCBI Gene Symbol: FGF-21
Gene Source: Human
Accession #: Q9JJN1
Recombinant: Yes
Source: E. coli.
Purity by SDS-PAGEs: 95%
Assay: SDS-PAGE
Purity: N/A
Assay #2: N/A
Endotoxin Level: N/A
Activity (Specifications/test method): N/A
Biological activity: Specific activity is > 30 unit/mg; One unit will convert 1.0 µmole of L-Alanine to L-Glutamate per minute at pH 7.5 at 37ºC.
Results: Specific activity is > 30 unit/mg
Binding Capacity: N/A
Unit Definition: One unit will convert 1.0 µmole of L-Alanine to L-Glutamate per minute at pH 7.5 at 37ºC.
Molecular Weight: 60.3 kDa (546 aa, 1-523 aa + His Tag)
Concentration: 0.5 mg/ml
Appearance: Liquid
Physical form description: 0.5 mg/ml solution 20 mM Tris-HCl buffer (pH 7.5), 30% glycerol, 0.2 M NaCl and 2 mM DTT.
Reconstitution Instructions: N/A
Amino acid sequence: MGSSHHHHHH SSGLVPRGSH MGSMQRAAAL VRRGCGPRTP SSWGRSQSSA AAEASAVLKV RPERSRRERI LTLESMNPQV KAVEYAVRGP IVLKAGEIEL ELQRGIKKPF TEVIRANIGD AQAMGQQPIT FLRQVMALCT YPNLLDSPSF PEDAKKRARR ILQACGGNSL GSYSASQGVN CIREDVAAYI TRRDGGVPAD PDNIYLTTGA SDGISTILKI LVSGGGKSRT GVMIPIPQYP LYSAVISELD AIQVNYYLDE ENCWALNVNE LRRAVQEAKD HCDPKVLCII NPGNPTGQVQ SRKCIEDVIH FAWEEKLFLL ADEVYQDNVY SPDCRFHSFK KVLYEMGPEY SSNVELASFH STSKGYMGEC GYRGGYMEVI NLHPEIKGQL VKLLSVRLCP PVSGQAAMDI VVNPPVAGEE SFEQFSREKE SVLGNLAKKA KLTEDLFNQV PGIHCNPLQG AMYAFPRIFI PAKAVEAAQA HQMAPDMFYC MKLLEETGIC VVPGSGFGQR EGTYHFRMTI LPPVEKLKTV LQKVKDFHIN FLEKYA